Cote d'Ivoire vs Ghana: The number of people with susceptibility test result for rifampicin
Cote d'Ivoire
8,494
in 2021
Ghana
8,532
in 2021
Cote d'Ivoire rank
25th
Ghana rank
24th
The number of people with susceptibility test result for rifampicin over time
- Cote d'Ivoire
- Ghana
How they compare
Ghana currently reports 8,532 against 8,494 in Cote d'Ivoire, a difference of 38.
Across all 5 years both countries report, Ghana has been ahead every year.
Cote d'Ivoire ranks 25th and Ghana ranks 24th of 155 countries.
Ghana has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cote d'Ivoire | Ghana | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3,175 | 8,062 | 4,887 | Ghana |
| 2020s | 4,890 | 8,274 | 3,384 | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Cote d'Ivoire or Ghana?
- Ghana, at 8,532 against 8,494 in Cote d'Ivoire as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Cote d'Ivoire and Ghana?
- 38, with Ghana ahead.
- How many years of comparable data are there for Cote d'Ivoire and Ghana?
- 5 years are reported by both, from 2017 to 2021.
- How do Cote d'Ivoire and Ghana rank globally for the number of people with susceptibility test result for rifampicin?
- Cote d'Ivoire ranks 25th and Ghana ranks 24th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.